Cibinqo
Brand Name: Cibinqo
Generic Name: Abrocitinib
Active
Registration Number
DR-XY48381
Dosage Form
Film-coated Tablet
Issuance Date
September 30, 2022
Expiry Date
September 30, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50 mg
PackagingPVC/PVDC-Alu Blister Pack x 7's (Box of 14's and Box of 14's as physician's sample)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Agent for Dermatitis (Janus Kinase Inhibitor)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AbrocitinibActive
Monograph: Abrocitinib